11/20
07:17 am
tech
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES [Yahoo! Finance]
Medium
Report
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES [Yahoo! Finance]
11/20
07:00 am
tech
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
Low
Report
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
11/18
07:12 am
tech
BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH [Yahoo! Finance]
Low
Report
BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH [Yahoo! Finance]
11/18
07:00 am
tech
BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
Low
Report
BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
11/14
07:09 am
tech
BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO [Yahoo! Finance]
Low
Report
BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO [Yahoo! Finance]
11/14
07:00 am
tech
BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO
Low
Report
BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO
11/12
02:01 am
tech
Bio-Techne Co. (NASDAQ: TECH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Bio-Techne Co. (NASDAQ: TECH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
11/11
05:52 pm
tech
UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS [Yahoo! Finance]
Low
Report
UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS [Yahoo! Finance]
11/11
05:47 pm
tech
UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
Low
Report
UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
11/11
07:00 am
tech
BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
Medium
Report
BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
11/8
07:00 am
tech
BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
Low
Report
BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
11/7
07:00 am
tech
ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy
Low
Report
ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy
11/6
01:46 pm
tech
There May Be Some Bright Spots In Bio-Techne's (NASDAQ:TECH) Earnings [Yahoo! Finance]
Low
Report
There May Be Some Bright Spots In Bio-Techne's (NASDAQ:TECH) Earnings [Yahoo! Finance]
11/6
07:00 am
tech
BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING
Medium
Report
BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING
11/6
12:16 am
tech
Beyond the Balance Sheet: What SWOT Reveals About Bio-Techne Corp (TECH) [Yahoo! Finance]
Medium
Report
Beyond the Balance Sheet: What SWOT Reveals About Bio-Techne Corp (TECH) [Yahoo! Finance]
11/5
07:00 am
tech
LUNAPHORE COMET™ PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH
Medium
Report
LUNAPHORE COMET™ PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH
11/1
11:06 pm
tech
Bio-Techne Co. (NASDAQ: TECH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Bio-Techne Co. (NASDAQ: TECH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
10/31
03:47 pm
tech
Bio-Techne Co. (NASDAQ: TECH) had its price target raised by analysts at Scotiabank from $83.00 to $88.00. They now have a "sector outperform" rating on the stock.
Low
Report
Bio-Techne Co. (NASDAQ: TECH) had its price target raised by analysts at Scotiabank from $83.00 to $88.00. They now have a "sector outperform" rating on the stock.
10/31
08:35 am
tech
Bio-Techne Co. (NASDAQ: TECH) had its price target raised by analysts at Robert W. Baird from $82.00 to $84.00. They now have an "outperform" rating on the stock.
Medium
Report
Bio-Techne Co. (NASDAQ: TECH) had its price target raised by analysts at Robert W. Baird from $82.00 to $84.00. They now have an "outperform" rating on the stock.
10/30
06:30 am
tech
BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
Medium
Report
BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
10/30
06:30 am
tech
BIO-TECHNE DECLARES DIVIDEND
Medium
Report
BIO-TECHNE DECLARES DIVIDEND
10/29
07:00 am
tech
ScaleReady Announces a G-Rex® Grant has been awarded to Luminary Therapeutics
Low
Report
ScaleReady Announces a G-Rex® Grant has been awarded to Luminary Therapeutics
10/28
03:55 pm
tech
Sodium Butyrate Market to grow by USD 72.6 Million from 2024-2028, driven by e-commerce and online health platform growth, with AI's impact on market trends - Technavio [Yahoo! Finance]
Low
Report
Sodium Butyrate Market to grow by USD 72.6 Million from 2024-2028, driven by e-commerce and online health platform growth, with AI's impact on market trends - Technavio [Yahoo! Finance]
10/28
06:14 am
tech
Internet of Medical Things (IoMT) Market Report 2024-2034, Featuring Profiles of Baxter, Bio Techne, Biotronik, Boston Scientific, Cisco Systems, GE Healthcare, IBM, Medtronic, Siemens and More [Yahoo! Finance]
Low
Report
Internet of Medical Things (IoMT) Market Report 2024-2034, Featuring Profiles of Baxter, Bio Techne, Biotronik, Boston Scientific, Cisco Systems, GE Healthcare, IBM, Medtronic, Siemens and More [Yahoo! Finance]
10/21
12:43 pm
tech
Bio-Techne Gears Up for Q1 Earnings Release: What's in the Cards? [Yahoo! Finance]
Low
Report
Bio-Techne Gears Up for Q1 Earnings Release: What's in the Cards? [Yahoo! Finance]